EFFECTIVENESS AND SAFETY OF SOFOSBUVIR AND DACLATASVIR COMBINATION FOR THE TREATMENT OF HEPATITIS C

Main Article Content

Dilaram Khan
Fakhre Alam
Mohammad Iltaf
Muhammad Kamran Hassan
Hashmatullah Khan
Amir Ghafoor

Abstract

Objective: To determine the effectiveness and safety of sofosbuvir and daclatsvir combination for the treatment of hepatitis C.

Methodology: This study, of 145 patients, was done in the OPDs of Gastroenterology Unit, LRH & HMC of Khyber Pakhtunkhwa, from January 1st 2017 to December 1st, 2017. HCV infected Patients aged more than 18 years, of either gender, irrespective of previous treatment status having normal hematological tests and ultrasound were included.

Results: Ninty three patients (64.13%) were male and 52 (35.86%) female. Mean age was 39.27 ±10.95. Genotype 3 was the most common genotype, present in 130 (89.65%) patients. All patients with HCV Genotype 3, Genotype 2 and Genotype 1 and untypeable had undetectable HCV RNA at week 4, while 122 (93.84%) patients with HCV Genotype 3; 6(85.71%) patients with Genotype 2; and 4(100%) each with Genotype 1 and untypeable had undetectable HCV RNA  twelve weeks after treatment completion. Ten (6.89%) patients developed fatigue, 9(6.20%) patients developed nausea while 8(5.51) patients complained of headache.

Conclusion: Combination of sofosbuvir and daclatasvir was found highly effective with high safety profile in HCV infected patients in our set up.

 

Article Details

How to Cite
1.
Khan D, Alam F, Iltaf M, Hassan MK, Khan H, Ghafoor A. EFFECTIVENESS AND SAFETY OF SOFOSBUVIR AND DACLATASVIR COMBINATION FOR THE TREATMENT OF HEPATITIS C. J Postgrad Med Inst [Internet]. 2019 Mar. 21 [cited 2022 Dec. 9];33(1). Available from: https://www.jpmi.org.pk/index.php/jpmi/article/view/2291
Section
Original Article
Author Biography

Dilaram Khan, Lady Reading Hospital peshawar

Assistant Professor department of gastroenterology unit Lady Reading Hospital Peshawar

Most read articles by the same author(s)

1 2 > >>